EOLS — Evolus, Inc. stock price, charts and financials

QT54Evolus, Inc.

Evolus, Inc. (NASDAQ: EOLS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.12
+0.07+1.16%
EOLSQT54Evolus, Inc.·NASDAQ
6.12+1.16%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Aug 04, 20268-KCurrent report
Jul 08, 20268-KCurrent report
Jun 12, 20268-KCurrent report
Jun 12, 2026EFFECTNotice of effectiveness
Jun 05, 2026S-3Shelf registration statement
May 04, 20268-KCurrent report
May 04, 202610-QQuarterly report
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
Apr 29, 2026ARSAnnual report to shareholders
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 20264Statement of changes in beneficial ownership
Mar 20, 20264Statement of changes in beneficial ownership
Mar 18, 20264Statement of changes in beneficial ownership
Mar 18, 20264Statement of changes in beneficial ownership
Mar 13, 20268-KCurrent report
Mar 03, 2026S-8Registration of employee benefit securities
Mar 03, 20268-KCurrent report
Mar 03, 202610-KAnnual report
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership